These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12476490)
21. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides. Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475 [TBL] [Abstract][Full Text] [Related]
22. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites. Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES Malar J; 2019 May; 18(1):186. PubMed ID: 31142328 [TBL] [Abstract][Full Text] [Related]
23. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Alloueche A; Milligan P; Conway DJ; Pinder M; Bojang K; Doherty T; Tornieporth N; Cohen J; Greenwood BM Am J Trop Med Hyg; 2003 Jan; 68(1):97-101. PubMed ID: 12556156 [TBL] [Abstract][Full Text] [Related]
24. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP. Rampling T; Ewer KJ; Bowyer G; Bliss CM; Edwards NJ; Wright D; Payne RO; Venkatraman N; de Barra E; Snudden CM; Poulton ID; de Graaf H; Sukhtankar P; Roberts R; Ivinson K; Weltzin R; Rajkumar BY; Wille-Reece U; Lee CK; Ockenhouse CF; Sinden RE; Gerry S; Lawrie AM; Vekemans J; Morelle D; Lievens M; Ballou RW; Cooke GS; Faust SN; Gilbert S; Hill AV J Infect Dis; 2016 Sep; 214(5):772-81. PubMed ID: 27307573 [TBL] [Abstract][Full Text] [Related]
25. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. al-Yaman F; Genton B; Anders R; Taraika J; Ginny M; Mellor S; Alpers MP Parasite Immunol; 1995 Sep; 17(9):493-501. PubMed ID: 8552419 [TBL] [Abstract][Full Text] [Related]
26. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum. Enders B; Hundt E; Knapp B Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721 [TBL] [Abstract][Full Text] [Related]
27. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. Matsumoto S; Yukitake H; Kanbara H; Yamada T J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886 [TBL] [Abstract][Full Text] [Related]
28. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine. Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983 [TBL] [Abstract][Full Text] [Related]
29. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. Genton B; Betuela I; Felger I; Al-Yaman F; Anders RF; Saul A; Rare L; Baisor M; Lorry K; Brown GV; Pye D; Irving DO; Smith TA; Beck HP; Alpers MP J Infect Dis; 2002 Mar; 185(6):820-7. PubMed ID: 11920300 [TBL] [Abstract][Full Text] [Related]